A negative binomial regression model for risk estimation of 0–2 axillary lymph node metastases in breast cancer patients
Abstract Extensive clinical trials indicate that patients with negative sentinel lymph node biopsy do not need axillary lymph node dissection (ALND). However, the ACOSOG Z0011 trial indicates that patients with clinically negative axillary lymph nodes (ALNs) and 1–2 positive sentinel lymph nodes hav...
Guardado en:
Autores principales: | De Zeng, Hao-Yu Lin, Yu-Ling Zhang, Jun-Dong Wu, Kun Lin, Ya Xu, Chun-Fa Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a7c45db41e544efa00cbce9103b0624 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
por: Floriane Pelon, et al.
Publicado: (2020) -
Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Yul Ri Chung, et al.
Publicado: (2021) -
The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma
por: Tian-Han Zhou, et al.
Publicado: (2021) -
Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance
por: Yamamoto D, et al.
Publicado: (2012) -
Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication
por: Fangfang Liu, et al.
Publicado: (2021)